tiprankstipranks
Trending News
More News >
DocGo (DCGO)
NASDAQ:DCGO
US Market

DocGo (DCGO) Earnings Dates, Call Summary & Reports

Compare
611 Followers

Earnings Data

Report Date
May 11, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
-0.11
Last Year’s EPS
-0.09
Same Quarter Last Year
Moderate Buy
Based on 5 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Mar 16, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed solid operational momentum and several concrete positive developments — raised 2026 revenue and adjusted EBITDA guidance, strong performance from SteadyMD and remote patient monitoring, meaningful volume growth across core services, hiring progress, and a clear efficiency roadmap with measurable savings. Offsetting these positives were substantial noncash impairments, a material year-over-year revenue drop tied to the one-time wind-down of migrant programs, a decline in cash balance and delayed receivables (~$20M) that create near-term working capital and covenant considerations, and margin pressure from elevated overtime and lower-margin legacy programs. On balance the company presented actionable plans (staffing, automation, cost-savings, and strategic review) and an improved outlook for 2026, suggesting operational recovery and path to adjusted EBITDA profitability later in the year despite near-term liquidity and accounting headwinds.
Company Guidance
DocGo raised 2026 revenue guidance to $290–$310 million (up from $280–$300M), implying 15%–23% growth over 2025, and narrowed expected adjusted EBITDA loss to $5–$10 million (vs prior $15–$25M), with management aiming for adjusted EBITDA profitability in the back half of 2026. The guide assumes a blended adjusted gross margin near ~33% for the year, segment mix of roughly $215M transport and $85–$88M mobile health on a ~$300M midpoint, SteadyMD contributing ~$25–$30M (SteadyMD Q4 revenue >$8M, $6.1M recorded by DocGo; SteadyMD FY interactions >4M comprising ~3M lab orders and ~1M telehealth visits, with gross margin improving from ~30% to 37%), and expected efficiency savings of ~$5–$6M in 2026 (and ~$20–$24M in 2027). Management cited recent traction against the Q4 2025 baseline ($74.9M Q4 revenue; Q4 adjusted EBITDA loss ~$11.3M; FY 2025 revenue $322.2M, adjusted EBITDA loss $28.6M), operational improvements (filled 206 of 546 EMT/paramedic openings; Q4 overtime ~13% trending down from 11–13% toward sub-10%/mid-single-digit targets), RPM strength (Q4 RPM revenue $4.0M and $830K adjusted EBITDA), care-gap assigned lives up 12% sequential to >1.45M, NPS 92, and cash dynamics (cash $68.3M vs $95.2M on Sept 30, $12.5M cash paid for SteadyMD + ~$1.5M transaction costs, ~ $20M migrant receivable outstanding); noted noncash impairments totaled ~$77M (goodwill $49.5M, intangibles $22.6M, equity investment $5M).
Revenue Beat and Raised 2026 Guidance
Q4 2025 revenue of $74.9 million beat the top end of guidance; 2026 revenue guidance increased to $290M–$310M (up $10M from prior guide), implying 15%–23% growth over 2025 base revenues.
Improved Adjusted EBITDA Outlook
Company narrowed expected 2026 adjusted EBITDA loss to $5M–$10M from prior $15M–$25M (improvement of $10M–$15M) and expects adjusted EBITDA profitability in the back half of 2026.
SteadyMD Strong Performance and Integration Upside
SteadyMD exceeded $8M in quarterly revenue (company recorded $6.1M in Q4 after Oct 20 acquisition); full-year interactions rose to >4 million (from ~2.5M in 2024); SteadyMD gross margin improved ~30% to 37%; SteadyMD contribution forecast in $25M–$30M range with upside.
Record Remote Patient Monitoring Results
Remote patient monitoring generated record Q4 revenue of $4.0M and $830k adjusted EBITDA; patients monitored increased 16% YoY; margins described as north of 50% with continued profitability improvement expected in 2026.
Strong Operational Volume Growth Across Key Metrics
Q4 vs Q4: medical transportation trips +11%, healthcare-in-the-home visits +113%, mobile phlebotomy +16%, remote patients monitored +16%, telehealth and lab orders +50%; care gap assigned lives rose 12% sequential to >1.45M; NPS of 92 (as of March 1).
Transport Segment Margin and Staffing Progress
Medical transportation adjusted gross margin improved to 32.8% in 2025 (from 30.1% in 2024); filled 206 of 546 open EMT/paramedic roles (improving hiring), overtime trending down from ~13% toward sub-10% target which should lift margins.
Efficiency Innovation Portfolio
Launched >12 projects targeting operating leverage; expected savings ~$5M–$6M in 2026 and ~$20M–$24M in 2027 via automation and process improvements (pre-billing automation, AgenTeq patient outreach integration).
Strategic Process Initiated
Company initiated a formal process to explore strategic alternatives to maximize shareholder value (investment bank engaged), providing a potential path to unlock value.

DocGo (DCGO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DCGO Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 11, 2026
2026 (Q1)
-0.11 / -
-0.09
Mar 16, 2026
2025 (Q4)
-0.14 / -1.37
-0.03-4466.67% (-1.34)
Nov 10, 2025
2025 (Q3)
-0.15 / -0.28
0.05-660.00% (-0.33)
Aug 07, 2025
2025 (Q2)
-0.10 / -0.11
0.06-283.33% (-0.17)
May 08, 2025
2025 (Q1)
-0.03 / -0.09
0.1-190.00% (-0.19)
Feb 27, 2025
2024 (Q4)
0.04 / -0.03
0.075-140.00% (-0.10)
Nov 07, 2024
2024 (Q3)
0.04 / 0.05
0.050.00% (0.00)
Aug 07, 2024
2024 (Q2)
0.06 / 0.06
-0.02400.00% (+0.08)
May 08, 2024
2024 (Q1)
0.08 / 0.10
-0.03433.33% (+0.13)
Feb 28, 2024
2023 (Q4)
0.10 / 0.07
0.11-31.82% (-0.04)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DCGO Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 16, 2026
$0.65$0.78+20.09%
Nov 10, 2025
$1.11$1.10-0.90%
Aug 07, 2025
$1.39$1.57+12.95%
May 08, 2025
$2.33$1.40-39.91%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does DocGo (DCGO) report earnings?
DocGo (DCGO) is schdueled to report earning on May 11, 2026, After Close (Confirmed).
    What is DocGo (DCGO) earnings time?
    DocGo (DCGO) earnings time is at May 11, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is DCGO EPS forecast?
          DCGO EPS forecast for the fiscal quarter 2026 (Q1) is -0.11.